AlphAIalphai — Financial news for AI agents
financialcontent.comSEP 32 min read$SWBI

Smith & Wesson (NASDAQ:SWBI) Delivers Strong Q2 CY2026 Numbers, Stock Soars

Smith & Wesson (SWBI) reported Q2 CY2026 revenue of $112.6M, up 32.3% YoY, exceeding estimates. Non-GAAP EPS was $0.06, above consensus. Analysts expect 3.1% revenue growth over the next 12 months. Operating margin improved to 3.7%. Stock rose 7.5% post-results.

Original reporting
financialcontent.com
Published Sep 3, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Smith & Wesson (NASDAQ:SWBI) Delivers Strong Q2 CY2026 Numbers, Stock Soars — source image
Source · financialcontent.com
Decision brief

The 30-second read

$SWBIBullishHigh
01

Why it matters

Earnings beat drives short‑term price rally but long‑term growth concerns remain.

02

Market read

The earnings surprise provides a fresh trading catalyst for SWBI with immediate price impact.

03

What to watch

Potential regulatory scrutiny on firearms industry could cap upside.

Relevance 7/10Novelty 8/10Timing: after-hours release

Background

Smith & Wesson reported a strong quarterly performance after a multi‑year revenue decline.

Company-level read

Ticker impact

$SWBIBullishHigh confidence
Context

Q2 CY2026 earnings beat with revenue $112.6M (+14.1% vs estimate) and adjusted EPS $0.06, driving a 7.5% stock rise.

Expected impact

Expect modest intraday rally; price may test $14 resistance.

Evidence & confidence

Beat on both top‑line and EPS, coupled with a 7.5% post‑report jump, suggests momentum continuation.

Market effects

Sector

Consumer discretionary firearms segment may see modest lift as earnings beat signals demand recovery.

Regional

U.S. small‑cap market gains modestly from the surprise.

Global

Limited; impact confined to U.S. equities.

Counterpoint

What could challenge this read

Revenue growth may be unsustainable; margin remains low, risk of future slowdown.

Key entities

  • Company
    Smith & Wesson

    Firearms manufacturer reporting Q2 CY2026 results.

Read at source← All news

Related articles

SEP 3
$IOTHighAI 8/10

After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM

Samsara (IOT) rose 11% on strong Q2 results and raised guidance. UiPath (PATH) climbed 13% with solid Q2 revenue and upbeat full-year outlook. Docusign (DOCU) gained 7% after a beat-and-raise Q2 report. Asana (ASAN) fell 12% on soft near-term profitability targets. Guidewire (GWRE) dropped 19% due to weak Q1 revenue guidance. Zscaler (ZS) edged up 1% on solid fiscal Q4 results. Planet Labs (PL) jumped 5% after reporting a surprise Q2 profit. Smith & Wesson (SWBI) surged 8.6% on strong Q1 sales.

investing.com3 min
SEP 3
$SWBIHigh

SMITH & WESSON BRANDS, INC. (SWBI): Results of Operations and Financial Condition

SMITH & WESSON BRANDS, INC. (SWBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Smith & Wesson Brands, Inc. Reports First Quarter Fiscal 2027 Financial Results - Q1 Net Sales of $112.6 Million - Q1 Gross Margin of 28.7% - Q1 EPS of $0.06/Share MARYVILLE, Tenn., September 3, 2026 – Smith & Wesson Brands, Inc. (NASDAQ Global Select: SWBI) , a U.S.

SEC EDGAR 8-K6 min
JUN 18
$SWBIMed

Smith & Wesson reports surge in firearms sales

Smith & Wesson reported a 27% year-over-year jump in fourth-quarter net sales to $178.4 million, citing strong handgun demand and new product rollouts, despite declining U.S. background checks. For fiscal 2026, it forecast net sales up more than 10% to $523.8 million. The company also plans major Springfield facility investments before April 2027.

boston.com4 min
JUN 18
$INTCMed

Wall Street futures bounce back as US-Iran deal optimism balances hawkish Fed

Wall Street futures rose after prior-session declines tied to expectations of further Fed rate hikes, with CME Group’s FedWatch showing a 50% chance of a 25 bp September move. Oil fell, supporting hopes inflation cools. US-Iran released an interim deal extending the ceasefire 60 days. Intel gained 8.4% on Trump’s comments about Apple chip work; Accenture fell 11.1% on a reduced revenue outlook.

freemalaysiatoday.com7 min